Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Accounts Payables (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Accounts Payables for 17 consecutive years, with $3.6 billion as the latest value for Q4 2025.

  • Quarterly Accounts Payables fell 0.75% to $3.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.6 billion through Dec 2025, down 0.75% year-over-year, with the annual reading at $3.6 billion for FY2025, 0.75% down from the prior year.
  • Accounts Payables for Q4 2025 was $3.6 billion at Bristol Myers Squibb, down from $4.3 billion in the prior quarter.
  • The five-year high for Accounts Payables was $5.4 billion in Q2 2025, with the low at $2.6 billion in Q3 2022.
  • Average Accounts Payables over 5 years is $3.4 billion, with a median of $3.2 billion recorded in 2023.
  • The sharpest move saw Accounts Payables decreased 20.14% in 2022, then surged 44.68% in 2025.
  • Over 5 years, Accounts Payables stood at $2.9 billion in 2021, then rose by 3.09% to $3.0 billion in 2022, then rose by 7.2% to $3.3 billion in 2023, then increased by 10.52% to $3.6 billion in 2024, then dropped by 0.75% to $3.6 billion in 2025.
  • According to Business Quant data, Accounts Payables over the past three periods came in at $3.6 billion, $4.3 billion, and $5.4 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.